Revascularization of ischemic tissues with SIKVAV and neuropeptide Y (NPY)

Advances in Experimental Medicine and Biology

Volumn 476, Issue , 2000, Pages 139-154

  Grant, Derrick ^a,b   Zukowska, Zofia ^a,b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; LAMININ; NEUROPEPTIDE Y; SERYLISOLEUCYLLYSYLVALYLALANYLVALINE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CAPILLARY; CONFERENCE PAPER; CONTROLLED STUDY; HINDLIMB; ISCHEMIA; LIGATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVASCULARIZATION; VASCULAR RING;

ANIMALS; EXTREMITIES; HUMANS; ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; NEUROPEPTIDE Y; OLIGOPEPTIDES; RATS;

ANIMALIA; HIATUS;

EID: 0034473483     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-4221-6_12     Document Type: Article

References (31)

1. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
2. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
3. Growth-promoting effects of catecholamines on rat aortic smooth muscle cells in culture
4. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells
5. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: Cooperation with noradrenaline and ATP
6. Angiogenesis in cancer, vascular, rheumatoid and other disease
7. Angiogenesis
8. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo
9. Basic fibroblast growth factor improves myocardial function in cronically ischemic porcine hearts
10. Angiogenesis for revascularization of ischaemic tissues
11. Manipulating angiogenesis against vascular disease
12. Clinical evidence of angiogenesis alter arterial gene transfer of phVEGF165 in patient with ischaemic limb
13. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease
14. Ischemic tissue injury
15. Exercise-induced changes in plasma catecholamines and neuropeptide Y: Relation to age and sampling times
16. Neuropeptide Y release from human heart is enhanced during prolonged exercise in hypoxia
17. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia
18. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: An in vivo Matrigel model
19. Cloning, functional expression, and developmental regulation of a neuropeptide Y receptor from Drosphila melanogaster
20. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV
21. Alpha-1 adrenergic receptor-induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells
22. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease
23. Elevated levels of basic fibroblast growth factor in patients with limb ischemia
24. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia
25. Inducible dipeptidyl peptidase IV in vascular smooth muscle cells: Role in neuropeptide Y-induced mitogenesis
26. Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart
27. Neuropeptide Y: Implications in vascular remodeling and novel therapeutics
28. Neuropeptide Y a novel angiogenic factor from the sympathetic nerves and endothelium
29. Endothelial Neuropeptide Y (NPY) system and angiogenesis
30. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells
31. Origin and actions of neuropeptide Y in the cardiovascular system